All three aurora kinases, AURKA-C, serve oncogenic roles in cancer by promoting cell cycle progression, cancer cell survival, and promoting MYC/MYCN expression and activity (Otto et al., 2009; Dauch et al., 2016; Willems et al., 2018). Here, MYC is linked to cancer.